Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Comment by skiptoggleon Jun 28, 2017 10:07am
289 Views
Post# 26413238

RE:RE:should't there not already be some infromation

RE:RE:should't there not already be some infromation For me there is no miracle short term recovery and the financials are not going to tell us much.  Blackbird have to deliver on the plan that they have so far stuck to (aside from the 3 hopefully 'minor' setbacks) .   A valuation of multiples of current share price in 2019 and beyond is what current shareholders are holding on for.  Still waiting for the GHA, which appears depend as much on surrounding companies as it does on Blackbird.  Despite all my negativity recently, I am holding on because fundamentally I see the full potential of this company is attainable with the plan in play.  Stage's performance to date is just a distraction.  

Would buy more BBI, but at current prices it would still  increase my avg cost per share.  Looking at RBC and Zacks target prices in the next 6-12 months still in the 1.08 to 1.25 range but Iexpect those to be trimmed after recent performance.



Bullboard Posts